British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine

British Health Professionals in Rheumatology; British Society for Rheumatology Standards, Audit and Guidelines Working Group

doi:10.1093/rheumatology/kead384

British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine

British Health Professionals in Rheumatology, British Society for Rheumatology Standards, Audit and Guidelines Working Group

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

14 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Rheumatology
Vol/bind	63
Udgave nummer	2
Sider (fra-til)	E37-E38
ISSN	1462-0324
DOI	https://doi.org/10.1093/rheumatology/kead384
Status	Udgivet - feb. 2024

Dokumenter og links

10.1093/rheumatology/kead384Licens: CC BY

Open Access VersionForlagets udgivne version, 447 KBLicens: CC BY

Citationsformater

@article{afd0bd18f27e410c929aeff293ccca22,

title = "British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine",

author = "Russell, {Mark D.} and Mrinalini Dey and Julia Flint and Philippa Davie and Alexander Allen and Amy Crossley and Margreta Frishman and Mary Gayed and Kenneth Hodson and Munther Khamashta and Louise Moore and Sonia Panchal and Madeleine Piper and Clare Reid and Katherine Saxby and Karen Schreiber and Naz Senvar and Sofia Tosounidou and {Van De Venne}, Maud and Louise Warburton and David Williams and Yee, {Chee Seng} and Caroline Gordon and Ian Giles and {British Health Professionals in Rheumatology} and {British Society for Rheumatology Standards, Audit and Guidelines Working Group}",

year = "2024",

month = feb,

doi = "10.1093/rheumatology/kead384",

language = "English",

volume = "63",

pages = "E37--E38",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "2",

}

British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine. / British Health Professionals in Rheumatology; British Society for Rheumatology Standards, Audit and Guidelines Working Group.
I: Rheumatology, Bind 63, Nr. 2, 02.2024, s. E37-E38.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - British Society of Rheumatology guideline working group response to European Medicines Agency safety update on Hydroxychloroquine

AU - Russell, Mark D.

AU - Dey, Mrinalini

AU - Flint, Julia

AU - Davie, Philippa

AU - Allen, Alexander

AU - Crossley, Amy

AU - Frishman, Margreta

AU - Gayed, Mary

AU - Hodson, Kenneth

AU - Khamashta, Munther

AU - Moore, Louise

AU - Panchal, Sonia

AU - Piper, Madeleine

AU - Reid, Clare

AU - Saxby, Katherine

AU - Schreiber, Karen

AU - Senvar, Naz

AU - Tosounidou, Sofia

AU - Van De Venne, Maud

AU - Warburton, Louise

AU - Williams, David

AU - Yee, Chee Seng

AU - Gordon, Caroline

AU - Giles, Ian

AU - British Health Professionals in Rheumatology

AU - British Society for Rheumatology Standards, Audit and Guidelines Working Group

PY - 2024/2

Y1 - 2024/2

U2 - 10.1093/rheumatology/kead384

DO - 10.1093/rheumatology/kead384

M3 - Journal article

C2 - 37522866

AN - SCOPUS:85184141540

SN - 1462-0324

VL - 63

SP - E37-E38

JO - Rheumatology

JF - Rheumatology

IS - 2

ER -